Bing Ma Selected Research

zirconium phosphate

11/2008	Antibacterial effect of dressings containing multivalent silver ion carried by zirconium phosphate on experimental rat burn wounds.
12/2004	[Experimental study on the antibacterial effects of zirconium phosphate gauze loaded with silver on the common bacteria on rat burn wound].

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Bing Ma Research Topics

Disease

35	Neoplasms (Cancer) 07/2022 - 08/2002
27	Inflammation (Inflammations) 01/2022 - 03/2002
19	Burns 01/2021 - 12/2004
14	Infections 02/2022 - 11/2007
13	Wounds and Injuries (Trauma) 12/2021 - 12/2004
12	Neoplasm Metastasis (Metastasis) 11/2021 - 08/2002
9	Fibrosis (Cirrhosis) 01/2020 - 03/2002
7	Sepsis (Septicemia) 01/2022 - 02/2010
7	Osteosarcoma (Osteogenic Sarcoma) 01/2021 - 04/2016
7	Asthma (Bronchial Asthma) 04/2015 - 07/2002
6	COVID-19 02/2022 - 01/2021
6	Cicatrix (Scar) 01/2022 - 02/2002
6	Hypertrophic Cicatrix (Hypertrophic Scar) 01/2021 - 02/2002
6	Diabetes Complications 11/2020 - 12/2011
6	Lung Injury 01/2016 - 04/2005
5	Pneumonia (Pneumonitis) 03/2021 - 03/2002
5	Melanoma (Melanoma, Malignant) 01/2021 - 05/2012
5	Breast Neoplasms (Breast Cancer) 01/2015 - 01/2008
5	Lewis Lung Carcinoma 08/2011 - 08/2002
4	Stroke (Strokes) 01/2021 - 04/2017
4	Acute Lung Injury 11/2014 - 04/2005
4	Metaplasia 11/2011 - 03/2002
3	Residual Neoplasm 12/2021 - 01/2019
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 11/2014
3	Hypertension (High Blood Pressure) 01/2021 - 04/2017
3	Gout 11/2017 - 09/2014
3	Pathologic Complete Response 12/2011 - 12/2011
3	Edema (Dropsy) 11/2011 - 07/2006
3	Shock 06/2010 - 04/2007
3	Respiratory Hypersensitivity 11/2007 - 07/2002
2	Liver Diseases (Liver Disease) 03/2022 - 12/2012
2	Hyperglycemia 01/2022 - 11/2009
2	Diabetes Mellitus 01/2022 - 09/2014
2	Pulmonary Fibrosis (Fibrosing Alveolitis) 01/2022 - 01/2019
2	Bone Resorption 11/2021 - 01/2016

Drug/Important Bio-Agent (IBA)

22	Proteins (Proteins, Gene)FDA Link 02/2022 - 08/2002
14	ChitinasesIBA 02/2022 - 01/2011
12	CytokinesIBA 09/2021 - 03/2003
10	Interleukin-13IBA 09/2015 - 03/2002
7	Biomarkers (Surrogate Marker)IBA 11/2020 - 12/2011
6	Biological ProductsIBA 03/2022 - 06/2004
6	Peptide Hydrolases (Proteases)FDA Link 02/2022 - 02/2004
6	HydrogelsIBA 12/2021 - 01/2011
6	Biocompatible Materials (Biomaterials)IBA 11/2021 - 01/2019
6	Messenger RNA (mRNA)IBA 08/2011 - 02/2002
5	EnzymesIBA 03/2022 - 08/2002
5	Therapeutic UsesIBA 03/2022 - 01/2019
5	Aldehyde Reductase (Aldose Reductase)IBA 01/2022 - 12/2011
5	Pharmaceutical PreparationsIBA 09/2021 - 11/2009
5	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 11/2009
5	Small Interfering RNA (siRNA)IBA 10/2018 - 06/2011
5	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2011 - 04/2005
4	IonsIBA 12/2021 - 09/2015
4	Matrix Metalloproteinases (MMPs)IBA 09/2021 - 08/2002
4	Oxidants (Oxidizing Agents)IBA 01/2016 - 04/2005
4	Epirubicin (Ellence)FDA LinkGeneric 12/2011 - 01/2008
4	Docetaxel (Taxotere)FDA Link 12/2011 - 01/2008
4	ChemokinesIBA 01/2006 - 03/2002
3	CreatinineIBA 07/2022 - 02/2010
3	polyolIBA 01/2022 - 11/2020
3	Toll-Like Receptor 4IBA 12/2021 - 05/2012
3	LigandsIBA 11/2021 - 05/2018
3	AntibodiesIBA 11/2021 - 02/2014
3	Mitogen-Activated Protein KinasesIBA 01/2020 - 01/2006
3	InterleukinsIBA 01/2018 - 07/2002
3	RNA (Ribonucleic Acid)IBA 12/2017 - 12/2004
3	Xanthine OxidaseIBA 11/2017 - 09/2014
3	LipopolysaccharidesIBA 11/2015 - 04/2014
3	InterferonsIBA 03/2012 - 12/2004
3	Transforming Growth Factor beta1 (TGF beta 1)IBA 04/2010 - 05/2006
3	Acetazolamide (Diamox)FDA LinkGeneric 07/2004 - 08/2002
2	AntigensIBA 03/2022 - 11/2015
2	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 01/2021
2	kasugamycinIBA 02/2022 - 01/2022
2	Blood Glucose (Blood Sugar)IBA 01/2022 - 11/2009
2	GlucosidasesIBA 01/2022 - 09/2014
2	Glucose (Dextrose)FDA LinkGeneric 01/2022 - 04/2021
2	NanovaccinesIBA 12/2021 - 01/2021
2	VaccinesIBA 12/2021 - 01/2016
2	AlginatesIBA 12/2021 - 01/2021
2	ManganeseIBA 11/2021 - 01/2021
2	CollagenIBA 01/2021 - 02/2010
2	SaltsIBA 01/2021 - 01/2021
2	Bone Cements (Bone Glue)IBA 01/2021 - 01/2019
2	16S Ribosomal RNAIBA 01/2021 - 01/2017
2	tetracarboxyphenylporphineIBA 01/2021 - 01/2020
2	Insulin (Novolin)FDA Link 01/2021 - 11/2009
2	SodiumIBA 01/2021 - 10/2005
2	AntioxidantsIBA 10/2020 - 02/2015
2	CateninsIBA 01/2020 - 08/2013
2	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 05/2018 - 01/2006

Therapy/Procedure

22	Therapeutics 01/2022 - 04/2007
6	Neoadjuvant Therapy 01/2015 - 01/2008
6	Resuscitation 12/2012 - 10/2005
3	Immunotherapy 12/2021 - 12/2020
3	Ligation 11/2015 - 09/2010
2	Photothermal Therapy 01/2021 - 01/2019
2	Transplantation 01/2020 - 02/2009
2	Length of Stay 01/2020 - 11/2007
2	Lasers (Laser) 01/2019 - 01/2019